The global Molecular Imaging Market is estimated to be valued at US$ 4786.94 Mn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Molecular Imaging involves non-invasive techniques to study cellular and subcellular functions within humans and other living systems by using probes like biomarkers, radionuclides that have been tagged to microscopic imaging devices. The technology aids early diagnosis of diseases and helps physicians to better understand disease mechanisms.
Market key trends:
One of the major trends in the molecular imaging market is the increasing demand for PET-MRI technology. PET-MRI combines positron emission tomography (PET) with magnetic resonance imaging (MRI) to acquire synergistic anatomical and molecular information. This technology provides greater diagnostic accuracy and improves patient management by facilitating precise localization of molecular and anatomical biomarkers. MRI also helps in attaining better soft tissue contrast compared to CT imaging. Furthermore, simultaneous acquisition allows temporal registration of functional and molecular information with high resolution anatomical details.
Segment Analysis
The global molecular imaging market is segmented into product, application, end user, and region. Based on product, the market is divided into positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), ultrasound imaging systems, and molecular optical imaging. Among these, the PET segment held the largest share of the market in 2021 and is expected to continue its dominance during the forecast period due to increasing use of PET for cancer screening.
Key Takeaways
The global Molecular Imaging Market Share is expected to witness high growth, exhibiting CAGR of 5.4% over the forecast period, due to increasing prevalence of cancer and cardiovascular diseases. The global molecular imaging market size is expected to reach US$ 4786.94 Mn by 2023.
Regional analysis
North America dominated the global molecular imaging market in 2021 and is expected to continue its dominance during the forecast period owing to increasing research activities and technological advancements in the region. Asia Pacific is expected to exhibit the fastest growth over the forecast period due to improving healthcare infrastructure, large patient pool, and rising medical tourism in the region.
Key players
Key players operating in the molecular imaging market are GE Healthcare, Bruker Corporation, Fujifilm Holdings Corp., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, United Imaging Healthcare Co., Ltd., Mediso Kft., Positron Corporation, Esaote SpA, Carestream Health, Mirada Medical Limited, and Hermes Medical Solutions. GE Healthcare maintained its dominance in the global molecular imaging market in 2021 owing to its wide product portfolio and strong geographic presence across the globe.
For more insights, Read- https://www.ukwebwire.com/molecular-imaging-market-trends-size-and-share-analysis/
Comments
0 comment